PTC Therapeutics, Inc. Initiates Phase 2 Clinical Trial of ataluren (PTC124(R)) in Patients with Hemophilia 10/26/2009
More...
|
Octapharma AG Targeting the Major Risk of Hemophilia Treatment 8/26/2009
More...
|
Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia 7/15/2009
More...
|
Bayer HealthCare (BAY): Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII Data Describing Prophylactic Treatment in Adults with Hemophilia A Presented 7/14/2009
More...
|
Neose Technologies, Inc. (NTEC) Announces Two Abstracts on GlycoPEGylated Factor VIIa Accepted for Presentation at the Hemophilia 2008 World Congress 5/27/2008
More...
|
FDA Approves Novo Nordisk, Inc. (NVO)'s NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors 5/13/2008
More...
|
Catalyst Biosciences, Inc. Selects Drug Development Candidate in Factor VIIa Program for Hemophilia 5/7/2008
More...
|
Nektar Therapeutics (NKTR) Extends Hemophilia Drug Deal with Baxter International, Inc. (BAX); Nektar will Receive up to $44 Million 12/20/2007
More...
|
China Hemophiliacs Face Dangerous Shortage of Drug 9/14/2007
More...
|
Bayer HealthCare AG (BAY) Awards $2.4 Million in Grant Funds to Advance the State of Hemophilia Care Throughout the World 7/11/2007
More...
|
Rhode Island Biotech EpiVax, Inc. Receives $500K Federal Grant to Reengineer FVIII using ''Immunoinformatics'' 6/27/2007
More...
|
Wyeth (WYE) Introduces Its First Training Kit to Help People With Hemophilia Learn Self-Infusion Techniques 6/22/2007
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Provides Euro 250.000 Grant to the World Federation of Hemophilia to Support Innovative Patient Care Research and Educational Initiatives 4/16/2007
More...
|
Wyeth (WYE) And Nautilus Biotech Announce Collaboration To Develop Hemophilia Therapies 2/5/2007
More...
|
Wyeth (WYE) And MediVas LLC Announce Research Partnership To Develop Advanced Hemophilia Therapies 2/5/2007
More...
|
Bayer Pharmaceuticals Corporation (CT) Searches For Hemophilia Leadership Development Program Intern 1/24/2007
More...
|
Bayer HealthCare AG (BAY) Introduces Free Product Trial Program For Kogenate(R) FS With BIO-SET(R) 7/17/2006
More...
|
Avigen, Inc. (AVGN) Announces Presentation Of Data At Hemophilia 2006 World Congress 5/25/2006
More...
|
Bayer HealthCare Pharmaceuticals Grant Promotes Groundbreaking Hemophilia Research And Education 5/23/2006
More...
|
Baxter International, Inc. (BAX) And Jerini AG Advance Program To Develop Non-Intravenous Hemophilia Therapy 5/18/2006
More...
|
Baxter Healthcare Corporation (BAX) Receives FDA Approval For Ultra-High Dosage Strength Of ADVATE For Hemophilia A 5/9/2006
More...
|
Baxter Healthcare Corporation (BAX) Highlights Work Of World Federation Of Hemophilia In Addressing Global Disparities In Hemophilia Care 4/13/2006
More...
|
Scientists Find Genetic Pathway That Could Lead To Drugs For Kidney Disease 2/3/2006
More...
|
Bayer HealthCare Introduces Kogenate(R) FS With BIO-SET(R) In The United States 1/20/2006
More...
|
American Society of Hematology Release: Preventive Care Reduces Bleeding In Children With Hemophilia 12/12/2005
More...
|
Bayer Healthcare, Biological Products (CA) (BAY) Products Completes Investigational New Drug Filing With FDA For Longer-Acting Kogenate Product; Company Ready To Begin Phase I Clinical Trials With Hemophilia A Patients 6/29/2005
More...
|
Asklepios BioPharmaceutical, Inc. And Bayer Healthcare, LLC Announce Collaboration On Gene Therapy For The Treatment Of Hemophilia 5/18/2005
More...
|
Bayer Biological Products Signs Exclusive Agreement With World Federation of Hemophilia To Fund International Nursing Fellowship Program; Bayer BP Strengthens Its Commitment To The Global Hemophilia Community 4/18/2005
More...
|
Hemophilia Drug Fights Most Lethal Form Of Stroke 2/24/2005
More...
|
Baxter Healthcare Corporation (BAX) Announces European Union Expanded Approval Of ADVATE For Use In Children With Haemophilia A Less Than Six Years Old 12/23/2004
More...
|
Hemosol (HMSL) Provides Corporate Update 12/9/2004
More...
|
Maxygen, Inc. (MAXY) Announces New Development Program And Product Development Prioritization; Will Stop Further Development Of Its Interferon Beta Program 12/6/2004
More...
|
More Side-Effect Fallout 11/23/2004
More...
|
Hubei Pharmaceutical Group, Ltd.'s (HBEI.OB) Xuejing(R) Makes Inroads Into China's Lucrative Haemostatic Products Market 11/23/2004
More...
|
Bayer Healthcare, Biological Products (NC) Signs Development Deal For Longer-Acting Kogenate(R) 11/22/2004
More...
|
Baxter International, Inc. (BAX) Submits Regulatory Application To Japanese Minister Of Health Seeking Approval Of ADVATE For Hemophilia A 10/22/2004
More...
|
Bayer Biological Products Release: New Adult Hemophilia Quality Of Life Tool Now Available For Hemophilia Community 10/20/2004
More...
|
Targeted Genetics (TGEN) Presents At 18th Annual North American Cystic Fibrosis Conference 10/15/2004
More...
|
Thousands Of UK Haemophiliacs May Be Infected With vCJD 9/10/2004
More...
|
Genetically Modified Fish Used To Make Human Protein 9/9/2004
More...
|
Bayer Healthcare, Biological Products (NC) Extends Support Of Landmark Study In Prophylactic Treatment Of Hemophilia 7/13/2004
More...
|
Bayer Healthcare, Biological Products (NC) Donates Kogenate(R) FS To World Federation of Hemophilia 6/28/2004
More...
|
Avigen (AVGN) To Realign Product Development Strategy; Discontinues Phase I Coagulin-B 5/28/2004
More...
|
Bayer Healthcare, Biological Products (NC) Products Helps World Federation of Hemophilia Launch International External Quality Assessment Scheme (IEQAS) 4/15/2004
More...
|
Baxter Healthcare Corporation (BAX) Receives Marketing Authorization From The European Commission For ADVATE To Treat Haemophilia 3/3/2004
More...
|
Hemophilia Foundation Of Michigan Works To Improve Women's Health 2/24/2004
More...
|
Avigen (AVGN) Reports 2003 Year-End Cash And Investments At $99 Million 2/11/2004
More...
|
Biovitrum AB Signs Agreement To Become Sole Supplier Of Wyeth's (WYE) Hemophilia Drug ReFacto 1/26/2004
More...
|
Genmab A/S (DK:GEN) And Sanquin Blood Supply Foundation Collaborate To Improve Hemophilia Treatment 12/16/2003
More...
|
Novo Nordisk (NVO) Teams With The National Hemophilia Foundation To Launch First Patient Website To Serve Needs Of People Managing Hemophilia With Inhibitors 11/7/2003
More...
|